Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2015, Article ID 236159, 8 pages
http://dx.doi.org/10.1155/2015/236159
Research Article

Artocarpin Induces Apoptosis in Human Cutaneous Squamous Cell Carcinoma HSC-1 Cells and Its Cytotoxic Activity Is Dependent on Protein-Nutrient Concentration

1Department of Dermatology, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
2Department of Dermatology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
3Division of Basic Medical Sciences, Department of Nursing, Chang Gung Institute of Technology and Chronic Diseases and Health Promotion Research Center, Chiayi, Taiwan
4Research Center for Industry of Human Ecology, Chang Gung University of Science and Technology, Kweishan, Taoyuan 33303, Taiwan
5Department of Fragrance and Cosmetic Science, College of Pharmacy, Kaohsiung Medical University, No. 100, Tzyou 1st Road, Kaohsiung 807, Taiwan
6Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan

Received 5 October 2014; Accepted 1 December 2014

Academic Editor: Didier Stien

Copyright © 2015 Stephen Chu-Sung Hu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. S. Preston and R. S. Stern, “Nonmelanoma cancers of the skin,” The New England Journal of Medicine, vol. 327, no. 23, pp. 1649–1662, 1992. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. J. Schmitt, A. Seidler, T. L. Diepgen, and A. Bauer, “Occupational ultraviolet light exposure increases the risk for the development of cutaneous squamous cell carcinoma: a systematic review and meta-analysis,” The British Journal of Dermatology, vol. 164, no. 2, pp. 291–307, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. G. D. Goldman, “Squamous cell cancer: a practical approach,” Seminars in Cutaneous Medicine and Surgery, vol. 17, no. 2, pp. 80–95, 1998. View at Publisher · View at Google Scholar · View at Scopus
  4. D. E. Rowe, R. J. Carroll, and C. L. Day Jr., “Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: implications for treatment modality selection,” Journal of the American Academy of Dermatology, vol. 26, no. 6, pp. 976–990, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Tanvetyanon, T. Padhya, J. McCaffrey et al., “Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck,” Head & Neck, 2014. View at Publisher · View at Google Scholar · View at PubMed
  6. S. S. Shamaun, M. Rahmani, N. M. Hashim et al., “Prenylated flavones from Artocarpus altilis,” Journal of Natural Medicines, vol. 64, no. 4, pp. 478–481, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. C.-W. Lee, H.-H. Ko, C.-C. Lin, C.-Y. Chai, W.-T. Chen, and F.-L. Yen, “Artocarpin attenuates ultraviolet B-induced skin damage in hairless mice by antioxidant and anti-inflammatory effect,” Food and Chemical Toxicology, vol. 60, pp. 123–129, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. C. W. Tzeng, F. L. Yen, L. T. Lin et al., “Antihepatoma activity of Artocarpus communis is higher in fractions with high Artocarpin content,” The Scientific World Journal, vol. 2014, Article ID 978525, 8 pages, 2014. View at Publisher · View at Google Scholar · View at PubMed
  9. Y.-T. Fu, C.-W. Lee, H.-H. Ko, and F.-L. Yen, “Extracts of Artocarpus communis decrease α-melanocyte stimulating hormone-induced melanogenesis through activation of ERK and JNK signaling pathways,” The Scientific World Journal, vol. 2014, Article ID 724314, 8 pages, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. T. Arung, K. Shimizu, and R. Kondo, “Inhibitory effect of isoprenoid-substituted flavonoids isolated from Artocarpus heterophyllus on melanin biosynthesis,” Planta Medica, vol. 72, no. 9, pp. 847–850, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  11. K. Shimizu, R. Kondo, K. Sakai, N. Takeda, and T. Nagahata, “The skin-lightening effects of artocarpin on UVB-induced pigmentation,” Planta Medica, vol. 68, no. 1, pp. 79–81, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. E. T. Arung, K. Shimizu, and R. Kondo, “Artocarpus plants as a potential source of skin whitening agents,” Natural Product Communications, vol. 6, no. 9, pp. 1397–1402, 2011. View at Google Scholar · View at Scopus
  13. S. Buranajaree, P. Donsing, R. Jeenapongsa, and J. Viyoch, “Depigmenting action of a nanoemulsion containing heartwood extract of Artocarpus incisus on UVB-induced hyperpigmentation in C57BL/6 mice,” Journal of Cosmetic Science, vol. 62, no. 1, pp. 1–14, 2011. View at Google Scholar · View at Scopus
  14. P. Donsing, N. Limpeanchob, and J. Viyoch, “Evaluation of the effect of Thai breadfruit's heartwood extract on melanogenesis-inhibitory and antioxidation activities,” Journal of Cosmetic Science, vol. 59, no. 1, pp. 41–58, 2008. View at Google Scholar · View at Scopus
  15. K. Shimizu, M. Fukuda, R. Kondo, and K. Sakai, “The 5α-reductase inhibitory components from heartwood of Artocarpus incisus: structure-activity investigations,” Planta Medica, vol. 66, no. 1, pp. 16–19, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. E. T. Arung, B. D. Wicaksono, Y. A. Handoko et al., “Cytotoxic effect of artocarpin on T47D cells,” Journal of Natural Medicines, vol. 64, no. 4, pp. 423–429, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. E. T. Arung, K. Yoshikawa, K. Shimizu, and R. Kondo, “Isoprenoid-substituted flavonoids from wood of Artocarpus heterophyllus on B16 melanoma cells: cytotoxicity and structural criteria,” Fitoterapia, vol. 81, no. 2, pp. 120–123, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. A.-R. Han, Y.-J. Kang, T. Windono, S. K. Lee, and E.-K. Seo, “Prenylated flavonoids from the heartwood of Artocarpus communis with inhibitory activity on lipopolysaccharide-induced nitric oxide production,” Journal of Natural Products, vol. 69, no. 4, pp. 719–721, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. W.-C. Lan, C.-W. Tzeng, C.-C. Lin, F.-L. Yen, and H.-H. Ko, “Prenylated flavonoids from Artocarpus altilis: antioxidant activities and inhibitory effects on melanin production,” Phytochemistry, vol. 89, pp. 78–88, 2013. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  20. M. Rajendran, P. Manisankar, R. Gandhidasan, and R. Murugesan, “Free radicals scavenging efficiency of a few naturally occurring flavonoids: a comparative study,” Journal of Agricultural and Food Chemistry, vol. 52, no. 24, pp. 7389–7394, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. S. Dej-Adisai, I. Meechai, J. Puripattanavong, and S. Kummee, “Antityrosinase and antimicrobial activities from Thai medicinal plants,” Archives of Pharmacal Research, vol. 37, no. 4, pp. 473–483, 2014. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  22. B. Botta, A. Vitali, P. Menendez, D. Misiti, and G. D. Monache, “Prenylated flavonoids: pharmacology and biotechnology,” Current Medicinal Chemistry, vol. 12, no. 6, pp. 717–739, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Zhang, M. Zhang, L. Yu, Y. Zhao, N. He, and X. Yang, “Antitumor activities of quercetin and quercetin-5',8-disulfonate in human colon and breast cancer cell lines,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1589–1599, 2012. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  24. J. Cai, X.-L. Zhao, A.-W. Liu, H. Nian, and S.-H. Zhang, “Apigenin inhibits hepatoma cell growth through alteration of gene expression patterns,” Phytomedicine, vol. 18, no. 5, pp. 366–373, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  25. L. Chang and M. Karin, “Mammalian MAP kinase signalling cascades,” Nature, vol. 410, no. 6824, pp. 37–40, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. H. J. Schaeffer and M. J. Weber, “Mitogen-activated protein kinases: specific messages from ubiquitous messengers,” Molecular and Cellular Biology, vol. 19, no. 4, pp. 2435–2444, 1999. View at Google Scholar · View at Scopus
  27. T. Boutros, E. Chevet, and P. Metrakos, “Mitogen-Activated Protein (MAP) kinase/MAP kinase phosphatase regulation: roles in cell growth, death, and cancer,” Pharmacological Reviews, vol. 60, no. 3, pp. 261–310, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  28. A. Krajarng, Y. Nakamura, S. Suksamrarn, and R. Watanapokasin, “α-Mangostin induces apoptosis in human chondrosarcoma cells through downregulation of ERK/JNK and Akt signaling pathway,” Journal of Agricultural and Food Chemistry, vol. 59, no. 10, pp. 5746–5754, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  29. C. Yu, Y. Minemoto, J. Zhang et al., “JNK suppresses apoptosis via phosphorylation of the proapoptotic Bcl-2 family protein BAD,” Molecular Cell, vol. 13, no. 3, pp. 329–340, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. D. M. Sabatini, “mTOR and cancer: insights into a complex relationship,” Nature Reviews Cancer, vol. 6, no. 9, pp. 729–734, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  31. J. E. Dancey, “Therapeutic targets: MTOR and related pathways,” Cancer Biology & Therapy, vol. 5, no. 9, pp. 1065–1073, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. D. A. Guertin and D. M. Sabatini, “Defining the role of mTOR in cancer,” Cancer Cell, vol. 12, no. 1, pp. 9–22, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. D. W. Boulton, U. K. Walle, and T. Walle, “Extensive binding of the bioflavonoid quercetin to human plasma proteins,” The Journal of Pharmacy and Pharmacology, vol. 50, no. 2, pp. 243–249, 1998. View at Google Scholar · View at Scopus
  34. M. I. Kaldas, U. K. Walle, H. van der Woude, J. M. McMillan, and T. Walle, “Covalent binding of the flavonoid quercetin to human serum albumin,” Journal of Agricultural and Food Chemistry, vol. 53, no. 10, pp. 4194–4197, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  35. C. Tesseromatis and A. Alevizou, “The role of the protein-binding on the mode of drug action as well the interactions with other drugs,” European Journal of Drug Metabolism and Pharmacokinetics, vol. 33, no. 4, pp. 225–230, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Schmidt, D. Gonzalez, and H. Derendorf, “Significance of protein binding in pharmacokinetics and pharmacodynamics,” Journal of Pharmaceutical Sciences, vol. 99, no. 3, pp. 1107–1122, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. M. K. Grandison and F. D. Boudinot, “Age-related changes in protein binding of drugs: implications for therapy,” Clinical Pharmacokinetics, vol. 38, no. 3, pp. 271–290, 2000. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. L. Fontana, R. M. Adelaiye, A. L. Rastelli et al., “Dietary protein restriction inhibits tumor growth in human xenograft models,” Oncotarget, vol. 4, no. 12, pp. 2451–2461, 2013. View at Google Scholar · View at Scopus
  39. C. Lee and V. D. Longo, “Fasting vs dietary restriction in cellular protection and cancer treatment: from model organisms to patients,” Oncogene, vol. 30, no. 30, pp. 3305–3316, 2011. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. E. Levine, J. A. Suarez, S. Brandhorst et al., “Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population,” Cell Metabolism, vol. 19, no. 3, pp. 407–417, 2014. View at Publisher · View at Google Scholar · View at PubMed